Retinal Biologics Market

Future Market Insights

Key Insight

The retinal biologics market is projected to grow from USD 30.5 billion in 2025 to USD 87.4 billion by 2035, at a CAGR of 11.1%. VEGF-A Antagonists will dominate with a 61.3% market share, while macular degeneration will lead the indication segment with a 44.7% share.

August 25, 2025

Anurag Sharma

194 Pages

Cite this Report

Retinal Biologics Market

https://www.futuremarketinsights.com/reports/retinal-biologics-market

License

Buy Now

Summary ToC Companies

Key Players

The Vanguard Group
Amgen
F. Hoffmann-La Roche Ag

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Retinal Biologics Market

Key Players

Similar Industry Reports